Cantor Fitzgerald Downgrades Allakos Inc. (ALLK) to Neutral, 'Lirentelimab Data Doesn't Deliver'

January 16, 2024 1:28 PM EST Send to a Friend
(Updated - January 16, 2024 1:29 PM EST)

Cantor Fitzgerald analyst Jennifer Kim downgraded Allakos Inc. (NASDAQ: ALLK) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login